DJ Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rose 1.11% to $479.79 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.59% to 5,954.50 and the Dow Jones Industrial Average rising 1.39% to 43,840.91.
The stock's rise snapped a four-day losing streak.
Vertex Pharmaceuticals Inc. closed 7.71% short of its 52-week high of $519.88, which the company achieved on November 8th.
The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ rose 1.96% to $209.03, Krystal Biotech Inc. (KRYS) rose 3.40% to $179.25, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 4.55% to $16.79.
Trading volume (2.4 M) eclipsed its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 28, 2025 16:37 ET (21:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。